Results 271 to 280 of about 761,204 (307)

Growth hormone treatment of subfertile males

Fertility and Sterility, 1996
To study spermatogenesis and sperm motility during GH therapy in infertile men.Prospective open study. Each patient was treated with GH for 12 weeks and followed for a total of 36 weeks with sampling of blood and semen.Outpatients studied at a clinical research unit of a university hospital.Nine oligozoospermic (
Ovesen, Per Glud, Jørgensen, J O, Ingerslev, J, Ho, K K, Orskov, H, Christiansen, J S   +5 more
openaire   +3 more sources

[Growth hormone deficiency. Treatment with growth hormone and body composition].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1998
Increased fat mass, decreased lean mass, muscular mass and bone mineral density are characteristic of the body composition in GH deficiency, GH treatment reverses these abnormalities. Body composition was determined in 20 young adults with GHD diagnosed in childhood, whose GH treatment was stopped 1 year earlier.
ANTONIAZZI, Franco, ZAMBONI, Giorgio, Radetti G., Mengarda F., LAURIOLA, Silvana, Serra A., Tatò L.   +6 more
openaire   +2 more sources

Growth Hormone (GH) Treatment in Achondroplasia

Journal of Pediatric Endocrinology and Metabolism, 1993
Achondroplasia is one of the most commonly known types of skeletal dysplasia in the adult leading to short stature. Before beginning growth hormone (GH) treatment of short stature in patients with achondroplasia, we evaluated their growth pattern and their hypothalamic-pituitary function, including GH secretion.
T, Yamate, S, Kanzaki, H, Tanaka, T, Kubo, T, Moriwake, M, Inoue, Y, Seino   +6 more
openaire   +2 more sources

Growth Hormone Treatment in Turner's Syndrome

Acta Paediatrica, 1986
ABSTRACT. A total of 21 patients with Turner's syndrome were treated with pituitary hGH and/or somatrem for 1–2 years. Plasma non‐esterified fatty acid increased significantly from 0.52 ± 0.06 to 1.30 ± 0.09 mEq/litre at 4 hours after injection of hGH, 4 IU (mean ± SEM, p < 0.001).
K, Takano, N, Hizuka, K, Shizume
openaire   +2 more sources

Growth hormone-releasing hormone: a new treatment for growth hormone deficiency

1989
The identification and synthesis of growth hormone-releasing hormone (GHRH) coincided with the realisation that Jacob-Creutzfeldt disease could be transmitted by extracted cadaveric GH. Fortunately, the acceleration in supplies of biosynthetic GH enabled treatment regimens to be continued and even extended, and the field of growth and its therapy has ...
R. J. M. Ross, M. A. Preece, G. M. Besser, M. O. Savage   +3 more
openaire   +1 more source

Growth Hormone Treatment in Adults with Growth Hormone Deficiency

1993
As a clinical entity, growth hormone (GH) deficiency in adulthood has previously received little attention. This has been due in part to a traditional view that GH is only of physiological importance during childhood and adolescence, when its effects are most visible and dramatic, despite the fact that GH secretion normally continues throughout adult ...
A. J. Weissberger, R. C. Cuneo, F. Salomon, G. A. McGauley, C. Lowy, P. H. Sönksen   +5 more
openaire   +1 more source

Biosynthetic Human Growth Hormone in the Treatment of Growth Hormone Deficiency

Acta Paediatrica, 1990
ABSTRACT. A total of 309 previously untreated children with growth hormone deficiency (GHD) (219 boys, 90 girls; mean age 8.4 ± 3.9 years, range 1.5‐19 years) were treated for up to 3 years in an ongoing trial designed to examine the long‐term efficacy and safety of biosynthetic somatropin (rhGH).
J H, Holcombe, P M, Conforti, A C, Wong, R G, Thompson, M W, Draper   +4 more
openaire   +2 more sources

Growth hormone treatment during pregnancy in a growth hormone-deficient woman

European Journal of Endocrinology, 1995
Müller J, Starup J, Christiansen JS, Jørgensen JOL, Juul A, Skakkebaek NE, Growth hormone treatment during pregnancy in a growth hormone-deficient woman. Eur J Endocrinol 1995;132:727–9. ISSN 0804–4643 Information on the course and outcome of pregnancies in growth hormone (GH)-deficient patients is sparse, and GH treatment during pregnancy in ...
Müller, J, Starup, J, Christiansen, J S, Jørgensen, J O, Juul, A, Skakkebaek, N E   +5 more
openaire   +2 more sources

Growth hormone treatment in Noonan syndrome

Pediatrics International, 1996
AbstractGrowth responses to growth hormone (GH) treatment in Noonan syndrome are compared with those in short children with the other growth disorders. The responses in Noonan syndrome are much less than those in children with GH deficiency, a little less than those in children with non‐endocrine short stature and almost the same as those in children ...
openaire   +2 more sources

Growth Hormone Treatment in Short Children

Acta Paediatrica, 1986
ABSTRACT. A study of 31 children with short stature was initiated in 1982. They received subcutaneous injections of pituitary hGH, 0.1 IU/kg/day; no adverse effects were seen and none of the patients acquired antibodies. Only the results of the first year are presented, as final height has not yet been attained.
openaire   +2 more sources